Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
16 Janeiro 2025 - 11:29PM
Edgar (US Regulatory)
Exhibit 99.1
SCHEDULE A
Directors and Executive Officers of Akoya Biosciences,
Inc.
Name |
Position |
Brian
McKelligon |
President,
Chief Executive Officer and Director |
Johnny
Elk |
Chief
Financial Officer |
Jennifer
Kamocsay |
General
Counsel |
Pascal
Bamford |
Chief
Clinical Officer |
Niro
Ramachandran |
Chief
Business Officer |
Robert
G. Shepler |
Director,
Chairman of the Board |
Thomas
Raffin |
Director |
Thomas
P. Schnettler |
Director |
Scott
Mendel |
Director |
Matthew
Winkler |
Director |
Myla
Lai-Goldman |
Director |
Quanterix (NASDAQ:QTRX)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Quanterix (NASDAQ:QTRX)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025